Brian Thomas, Metagenomi CEO

Mod­er­na tries its hand at CRISPR through a new de­vel­op­ment pact with Metageno­mi

Mod­er­na has al­ways been think­ing about how mR­NA could trans­form the gene edit­ing space, ac­cord­ing to Er­ic Huang. In fact, they looked at it about a decade ago — but at the time, they were still a small, pre­clin­i­cal biotech, and tech­nol­o­gy like that would take some time to ma­ture.

Then the pan­dem­ic hit, and the rest is his­to­ry.

“Now, I think it’s the right time,” said Huang, CSO of Mod­er­na’s ge­nomics busi­ness.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.